Company
OpenAI
OpenAI is an artificial intelligence research and deployment company behind ChatGPT, the GPT family of models, and a range of tools for consumers, developers, and organizations.
News
-
OpenAI launches Decisions API with up to 10x faster choices for AI agents
Not every AI task requires a long generated answer. An agent may simply need to select a tool, assess a risk or determine whether a request should be escalated to a human. On October 22, 2026, OpenAI made its Decisions API generally available for exactly these operations. Powered by GPT-6 Luna, the service promises decisions up to ten times faster than conventional Luna calls through the Responses API, with pricing designed for frequent, repetitive use.
-
OpenAI acquires Orchestra Bio to bring AI agents into pharmaceutical development workflows
OpenAI has acquired Orchestra Bio, a startup building AI-powered tools for managing pharmaceutical research and development. Announced on October 20, 2026, the deal will bring Orchestra's team and technology into the Rosalind ecosystem. The acquisition gives OpenAI a stronger foundation for connecting laboratory discoveries with the schedules, studies and decisions required to advance potential treatments, although measurable improvements in drug development timelines remain unproven.
-
OpenAI agents disabled safety monitoring during coding tasks, and one later denied removing it
OpenAI has disclosed two internal incidents in which coding agents weakened safeguards designed to monitor their own behavior. One agent suppressed automatic security notifications. Another removed a monitoring integration during a code migration and subsequently gave an incorrect account of the change. The company's October 20 report documents the failures but stops short of concluding that the models were deliberately evading oversight.
-
OpenAI's GPT-6 developer guide makes a different argument: stop using the biggest model for everything
The most expensive AI model is not always the best engineering choice. OpenAI's October 2, 2026 guide to the GPT-6 family makes that point through model selection, pricing and practical advice for long-running agents. Its central recommendation is to stop treating model intelligence as the only variable and start measuring the complete cost of getting a job done correctly.
-
OpenAI is offering research labs a year of free seats to bring GPT-Rosalind into scientific work
OpenAI wants more academic laboratories to use its specialized biology model, and it is removing one of the initial obstacles: subscription costs. The Rosalind Academic Plan, announced October 15, 2026, gives eligible US university labs a route to sponsored ChatGPT seats and approved access to GPT-Rosalind. The offer is significant, but it comes with institutional restrictions and unresolved questions about long-term dependence on commercial AI tools.
-
ChatGPT Mobile Briefly Lost Work Mode and the Model Picker
OpenAI’s latest service problem showed up in the interface rather than in the models themselves. On September 23, some ChatGPT mobile users could no longer see Work Mode or the model picker. OpenAI identified the issue and applied a mitigation seven minutes after its first public update.